Psychedelic Finance – Geoff Belair | Chief Technology Officer, MINDCURE

Psychedelic Finance interviewed MINDCURE CTO Geoff Belair about iSTRYM which he describes as having “limitless” potential. This first MVP release is meant for its testing and development. Its intention is to guide both professional and patient through the psychedelic journey by providing many more touchpoints than previously available. The adoption of technology in psychedelic-assisted psychotherapy creates more options for patients.

Access the article here.